"Etiocholanolone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
Descriptor ID |
D005043
|
MeSH Number(s) |
D04.210.500.054.040.368 D04.210.500.578.502.583 D06.472.040.502.583 D06.472.334.851.968.968
|
Concept/Terms |
Etiocholanolone- Etiocholanolone
- 5-beta-Androsterone
- 5 beta Androsterone
- 3-alpha-Hydroxy-5-beta-Androstan-17-One
- 3 alpha Hydroxy 5 beta Androstan 17 One
|
Below are MeSH descriptors whose meaning is more general than "Etiocholanolone".
Below are MeSH descriptors whose meaning is more specific than "Etiocholanolone".
This graph shows the total number of publications written about "Etiocholanolone" by people in this website by year, and whether "Etiocholanolone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 2 | 0 | 2 |
2009 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Etiocholanolone" by people in Profiles.
-
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
-
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? Heart Fail Rev. 2009 Dec; 14(4):277-87.
-
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 2008 May-Jun; 15(3):231-40.
-
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
-
Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J Invest Dermatol. 1984 Jan; 82(1):62-6.
-
Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab. 1983 Jan; 56(1):139-46.
-
The effect of formalin and the duration of acid hydrolysis on free and conjugated urinary 17-ketosteroids. Clin Chem. 1968 Nov; 14(11):1125-30.